-
Je něco špatně v tomto záznamu ?
Rat cytochromes P450 oxidize 2-nitrophenol, a human metabolite of carcinogenic 2-nitroanisole
M. Svobodova, M. Martinkova, H. Dracinska, E. Frei, M. Stiborova
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20027144
Knihovny.cz E-zdroje
- MeSH
- anisoly metabolismus MeSH
- inhibiční koncentrace 50 MeSH
- inhibitory cytochromu P450 MeSH
- jaterní mikrozomy enzymologie metabolismus MeSH
- kinetika MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- nitrofenoly metabolismus MeSH
- oxidace-redukce MeSH
- rekombinantní proteiny antagonisté a inhibitory metabolismus MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- ultrafialové záření MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: 2-Nitrophenol (2-NP) is the major detoxification metabolite of an important industrial pollutant and a potent carcinogen, 2-nitroanisole (2-NA). Characterization of the products of 2-NP metabolism by rat hepatic microsomes containing cytochromes P450 (CYPs) and identification of the major CYP enzymes participating in this process are aims of this study. METHODS: HPLC with UV detection was employed for the separation and characterization of 2-NP metabolites. Inducers and inhibitors of CYPs and rat recombinant CYPs were used to characterize the enzymes participating in 2-NP oxidation. RESULTS: Rat hepatic microsomes oxidize 2-NP to its hydroxylated metabolite, 2,5-dihydroxynitrobenzene (2,5-DNB). No nitroreductive metabolism leading to the formation of o-aminophenol was evident when using rat hepatic microsomes. Selective CYP inhibitors and hepatic microsomes of rats pre-treated with specific CYP inducers were used to characterize CYPs oxidizing 2-NP in rat livers. Based on these studies, we attribute most of 2-NP oxidation in rat liver to CYP2E1 and 3A, followed by CYP2D and 2C. Among recombinant rat CYP enzymes tested in this study, CYP2E1 and 2C11 were the most effective enzymes oxidizing 2-NP. Oxidation of 2-NP by rat CYP2E1 exhibits the Michaelis-Menten kinetics, having the Km value of 0.35 mM. CONCLUSION: The results found in this study, the first report on the metabolism of 2-NP by rat hepatic microsomes and rat CYP enzymes, demonstrate that CYP2E1 is the major enzyme oxidizing this compound in rat liver.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025396
- 003
- CZ-PrNML
- 005
- 20130128185322.0
- 007
- ta
- 008
- 120816s2009 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20027144
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Svobodová, Martina $7 xx0145338 $u Department of Biochemistry, Charles University, Prague, Czech Republic.
- 245 10
- $a Rat cytochromes P450 oxidize 2-nitrophenol, a human metabolite of carcinogenic 2-nitroanisole / $c M. Svobodova, M. Martinkova, H. Dracinska, E. Frei, M. Stiborova
- 520 9_
- $a OBJECTIVES: 2-Nitrophenol (2-NP) is the major detoxification metabolite of an important industrial pollutant and a potent carcinogen, 2-nitroanisole (2-NA). Characterization of the products of 2-NP metabolism by rat hepatic microsomes containing cytochromes P450 (CYPs) and identification of the major CYP enzymes participating in this process are aims of this study. METHODS: HPLC with UV detection was employed for the separation and characterization of 2-NP metabolites. Inducers and inhibitors of CYPs and rat recombinant CYPs were used to characterize the enzymes participating in 2-NP oxidation. RESULTS: Rat hepatic microsomes oxidize 2-NP to its hydroxylated metabolite, 2,5-dihydroxynitrobenzene (2,5-DNB). No nitroreductive metabolism leading to the formation of o-aminophenol was evident when using rat hepatic microsomes. Selective CYP inhibitors and hepatic microsomes of rats pre-treated with specific CYP inducers were used to characterize CYPs oxidizing 2-NP in rat livers. Based on these studies, we attribute most of 2-NP oxidation in rat liver to CYP2E1 and 3A, followed by CYP2D and 2C. Among recombinant rat CYP enzymes tested in this study, CYP2E1 and 2C11 were the most effective enzymes oxidizing 2-NP. Oxidation of 2-NP by rat CYP2E1 exhibits the Michaelis-Menten kinetics, having the Km value of 0.35 mM. CONCLUSION: The results found in this study, the first report on the metabolism of 2-NP by rat hepatic microsomes and rat CYP enzymes, demonstrate that CYP2E1 is the major enzyme oxidizing this compound in rat liver.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anisoly $x metabolismus $7 D000840
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a jaterní mikrozomy $x enzymologie $x metabolismus $7 D008862
- 650 _2
- $a nitrofenoly $x metabolismus $7 D009596
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a rekombinantní proteiny $x antagonisté a inhibitory $x metabolismus $7 D011994
- 650 _2
- $a ultrafialové záření $7 D014466
- 650 _2
- $a inhibitory cytochromu P450 $7 D065607
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Martínková, Markéta. $7 _AN059396
- 700 1_
- $a Dračínská, Helena $7 xx0077061
- 700 1#
- $a Frei, Eva. $7 _AN036392
- 700 1_
- $a Stiborová, Marie, $d 1950-2020 $7 jo2005259907
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 46-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20027144 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130128185503 $b ABA008
- 999 __
- $a ok $b bmc $g 947438 $s 782742
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 30 Suppl 1 $d 46-51 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120816/10/02